View Author
patient disease angioplasty artery revascularization surgery treatment decision study artery disease trial group survival multivessel disease multivessel ptca decisions lesion outcome heart vessel procedure percutaneou randomized percutaneous transluminal type c lesions intervention appropriateness follow-up table result centre netherland panel difference segment completeness angina number therapy mortality ducat stent infarction stented cabg decisions event-free survival transluminal treatment strategy revascularized signi 30 days ducat panel fi ve years event intention signi ficantly revascularisation graft indication strategy 20 years stented angioplasty population type c lesion baseline characteristics heart centres characteristic diabetes baseline cabg group comparison cardiol arts trial reintervention health fference clinician curve brand cardiology